Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Exhibits strong binding affinity in targeted therapies, especially in compounds designed to inhibit protein tyrosine kinases involved in tumor growth and inflammation. Its structure supports enhanced selectivity and metabolic stability, making it valuable in optimizing drug candidates for improved efficacy and reduced side effects. Also employed in research settings to study signal transduction pathways and enzyme inhibition mechanisms.